Publications & Works

Publication Network
Articles 6
All (6)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (6)
ESCI (1)
Scopus (6)
TRDizin (1)

1. The Schrödinger's Cat Paradox: Can MAMMI PET with 68Ga-FAPI Determine Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Omitting Surgery?

OFLAS M., HAS ŞİMŞEK D., YILMAZ R. S., CABIOĞLU N., ÖNDER S., IŞIK E. G., et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS , 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Paget’s Disease Mimicking Prostate Cancer Metastasis with 68Ga-PSMA PET/CT 68Ga-PSMA PET/BT’de Prostat Kanseri Metastazını Taklit Eden Paget Hastalığı

Oflas M., Işık E. G., Özkan Z. G., Has Şimşek D., Şanlı Y.
Molecular Imaging and Radionuclide Therapy , vol.33, no.3, pp.199-202, 2024 (ESCI, Scopus, TRDizin) Creative Commons License Sustainable Development identifier identifier

3. Combination of 68Ga-FAPI-04 and Dedicated Breast PET (MAMMI PET) Outperformed Breast MRI and 18F-FDG PET/CT by Revealing Nipple and Skin Involvement of Breast Cancer

Has Simsek D., Oflas M., Yilmaz R., Tukenmez M., Kuyumcu S.
CLINICAL NUCLEAR MEDICINE , vol.49, no.6, 2024 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

4. Ga-68-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes

Oflas M., Ozluk Y., Sanli O., Ozkan Z. G., Kuyumcu S.
CLINICAL NUCLEAR MEDICINE , vol.47, no.1, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

5. Prognostic value of FDG PET-CT in suspected recurrence of colorectal carcinoma: survival outcomes of a 10-year follow-up : FDG PET in recurrent colorectal CA.

ozkan Z. G., Has Simsek D., Kuyumcu S., Oflas M., Isik E. G., Dogan I., et al.
Annals of nuclear medicine , vol.36, no.1, pp.52-60, 2022 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier

6. Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?

Has Simsek D., Kuyumcu S., Karadogan S., Oflas M., Isik E. G., Ozkan Z. G., et al.
ANNALS OF NUCLEAR MEDICINE , vol.35, no.6, pp.680-690, 2021 (SCI-Expanded, Scopus) Sustainable Development identifier identifier identifier
Papers Presented at Peer-Reviewed Scientific Conferences 10

1. The correlation between tumor dosimetry and clinical parameters with therapy response and overall survival in patients with hepatocellular carcinoma, who underwent transarterial radioembolization treatment

Oflas M., HAS ŞİMŞEK D., IŞIK E. G., KUYUMCU S., ÖZKAN Z. G., POYANLI A., et al.
Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Hamburg, Germany, 19 - 23 October 2024, vol.51, (Summary Text) identifier

2. The efficacy of prognostic factors derived from Ga68-PSMA PET-CT images in predicting treatment response and survival in patients with metastatic castration-resistant prostate cancer treated with Lu-177PSMA

Oflas M., Has Şimşek D., Şanlı Y., Kuyumcu S., Işık E. G., Karadoğan S., et al.
EANM’23, Vienna, Austria, 9 - 13 September 2023, (Full Text) Sustainable Development

3. LU177-PSMA TEDAVİSİ VERİLEN PROSTAT KANSERLİ HASTALARDA GA-68 PET/BT İLE TEDAVİ YANITI VE PROGNOSTİK DEĞERLENDİRME

Oflas M., Has Şimşek D., Şanlı Y., Kuyumcu S., Işık E. G., Karadoğan S., et al.
35. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 26 - 30 April 2023, (Summary Text) Sustainable Development

4. The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer

Oflas M., Has Şimşek D., Işık E. G., Cabıoğlu N., İbiş K., Aydıner A., et al.
35'th Annual Congress of Nuclear Medicine, Barcelona, Spain, 15 - 19 October 2022, (Summary Text)

5. Karaciğerde maligniteyi taklit eden IgG4 ilişkili hastalık saptanan olgunun tedavi öncesi ve sonrası 18F- FDG PET/BT bulguları

Oflas M., Has Şimşek D., Şanlı Y., Mudun A., Ünal S. N.
34. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 27 - 31 March 2022, pp.116, (Full Text)

6. The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer

Oflas M., Has Şimşek D., Işık E. G., Cabıoğlu N., İbiş K., Aydıner A., et al.
34. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 27 - 31 March 2022, pp.51, (Summary Text) Sustainable Development

7. POST-COVID PE ŞÜPHESİNDE Q SPECT-BT’NİN KLİNİK BULGULAR İLE DEĞERLENDİRİLMESİ

Denizmen D., Işık E. G., Oflas M., Has Şimşek D., Arslan D. F., Özkan Z. G., et al.
34. UNTK, Antalya, Turkey, 27 - 31 March 2022, pp.44, (Full Text) Creative Commons License

8. MEME KANSERLİ HASTALARDA NEOADJUVAN TEDAVİ SONRASI PATOLOJİK YANITIN ÖNGÖRÜLMESİNDE 18F-FDG PET/BT’NİN ROLÜ

Oflas M., Has Şimşek D., Işık E. G., Emirikçi S., Cabıoğlu N., Müslümanoğlu M. E., et al.
33. Ulusal Nükleer Tıp Kongresi, İstanbul, Turkey, 28 - 29 May 2021, pp.10-11, (Summary Text) Creative Commons License Sustainable Development

9. COVID-19 Sonrası Emboli Şüphesi Olan Hastalarda Yapılan Akciğer Perfüzyon Sintigrafisi Bulgularının Değerlendirilmesi

Oflas M., Işık E. G., Kıran M. Y., Denizmen D., Erelel M., Özkan Z. G.
33. Ulusal Nükleer Tıp Kongresi, İstanbul, Turkey, 28 - 29 May 2021, pp.1-2, (Full Text) Creative Commons License Sustainable Development

10. Kolorektal Kanser Tanılı Hastalarda Sağkalımı Öngörmede Florodeoksiglukoz Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi ve Serum Karsinoembriyojenik Antijen Değerinin Rolü

OFLAS M., HAS ŞİMŞEK D., IŞIK E. G., KIRAN M. Y., DOĞAN İ., KARABULUT S., et al.
32. ULUSAL NÜKLEER TIP KONGRESİ, Turkey, 20 - 21 November 2020, vol.6, pp.16-17, (Summary Text)
Metrics

Publication

16

Publication (WoS)

7

Publication (Scopus)

6

Citation (WoS)

31

H-Index (WoS)

2

Citation (Scopus)

33

H-Index (Scopus)

2

Citation (Scholar)

21

H-Index (Scholar)

1

Open Access

3
UN Sustainable Development Goals